Overview

Dexmedetomidine Dose-Dependent on Lung Function and AQP1 in One-Lung Ventilation Surgery

Status:
COMPLETED
Trial end date:
2019-03-29
Target enrollment:
Participant gender:
Summary
This randomized controlled trial evaluated the dose-dependent effects of dexmedetomidine (DEX) on pulmonary function and aquaporin-1 (AQP1) expression during one-lung ventilation (OLV) in thoracoscopic surgery.
Phase:
NA
Details
Lead Sponsor:
People's Hospital of Guangxi Zhuang Autonomous Region
Treatments:
Dexmedetomidine
Sodium Chloride